Fluoroalkane Engineered Magnetic Vectors Unlock the Potential of Gasdermin in Vivo Delivery for Pyroptosis Induced Cancer Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40231596.
- Also identified by DOI 10.1002/adhm.202500801.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pyroptosis, a programmed necrotic cell death mediated by gasdermin, can activate strong immune responses and serve as a potential target for cancer therapy. Nevertheless, the relatively large molecular size and negative surface charge of gasdermin impede them from effectively intracellular delivery and directly inducing pyroptosis. Here, a cytosolic protein delivery system, fluorinated iron oxide nanoparticles (FIONPs) is reported, which can self-assemble with active gasdermin A3 protein (GSDMA3) via noncovalent interactions and effectively trigger pyroptosis in 4T1 cells. It is proved that the delivery system is versatile for various cargo proteins (ribonuclease A, saporin, β-galactosidase, and bovine serum albumin) with different isoelectric points and molecular weights, without compromising their biological activity in vitro. What's more, under magnetic drive, FIONPs facilitate active transport of GSDMA3 in vivo, further augmenting tumor suppression and immune response. Overall, magnetic-driven FIONPs provide an effective delivery system for intracellular protein transductions, and the application of the delivery system reveals that direct delivery of GSDMA3 significantly elicits robust antitumor immunity via the induction of pyroptosis.
Medical subject headings
- Pyroptosis
- Neoplasms
- Magnetic Iron Oxide Nanoparticles